| scholarly article | Q13442814 |
| P2093 | author name string | Qian Xie | |
| Sandeep Mittal | |||
| Michael E Berens | |||
| P2860 | cites work | VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex | Q24293027 |
| MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells | Q24603505 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Modes of resistance to anti-angiogenic therapy | Q24608005 | ||
| ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion | Q24623558 | ||
| MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib | Q24646295 | ||
| An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
| Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
| Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
| IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas | Q24656269 | ||
| Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
| Stable low-level expression of p21WAF1/CIP1 in A549 human bronchogenic carcinoma cell line-derived clones down-regulates E2F1 mRNA and restores cell proliferation control | Q25255281 | ||
| The p75 neurotrophin receptor is a central regulator of glioma invasion | Q27334481 | ||
| Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma. | Q48588707 | ||
| Identification of intrinsic in vitro cellular mechanisms for glioma invasion. | Q48963582 | ||
| Evolutionary game theory in an agent-based brain tumor model: exploring the 'Genotype-Phenotype' link | Q51378835 | ||
| Phenotypic diversity, population growth, and information in fluctuating environments | Q51965535 | ||
| Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. | Q53201476 | ||
| Glioblastoma multiforme metastasis outside the CNS: three case reports and possible mechanisms of escape. | Q55461135 | ||
| The natural history of extracranial metastasis from glioblastoma multiforme | Q55463169 | ||
| MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 | ||
| Glioma stem cells promote radioresistance by preferential activation of the DNA damage response | Q27860541 | ||
| Stem cells, cancer, and cancer stem cells | Q27860878 | ||
| Identification of a cancer stem cell in human brain tumors | Q28131688 | ||
| A cell initiating human acute myeloid leukaemia after transplantation into SCID mice | Q28131777 | ||
| ATR/ATM-mediated phosphorylation of human Rad17 is required for genotoxic stress responses | Q28202998 | ||
| Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits | Q28237197 | ||
| Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells | Q28264780 | ||
| Neural stem cells and the origin of gliomas | Q28268847 | ||
| Why do cancers have high aerobic glycolysis? | Q28290710 | ||
| The somatic genomic landscape of glioblastoma | Q28300185 | ||
| HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption | Q28300415 | ||
| Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma | Q29615607 | ||
| Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines | Q29615823 | ||
| Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis | Q29616712 | ||
| Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor | Q29617062 | ||
| Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion | Q29617359 | ||
| Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma | Q29617568 | ||
| Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis | Q29617613 | ||
| Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 | ||
| Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis | Q30430565 | ||
| Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. | Q33198814 | ||
| Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma | Q33382596 | ||
| The transcriptional network for mesenchymal transformation of brain tumours. | Q33572162 | ||
| EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. | Q33756853 | ||
| Proliferation and invasion: plasticity in tumor cells | Q33906737 | ||
| Potential therapeutic implications of cancer stem cells in glioblastoma | Q33965491 | ||
| Temozolomide and treatment of malignant glioma. | Q33983627 | ||
| Erythropoietin Receptor Signaling Through STAT3 Is Required For Glioma Stem Cell Maintenance | Q34006181 | ||
| Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. | Q34032640 | ||
| A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy | Q34132643 | ||
| Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state | Q34178901 | ||
| Gliomagenesis: genetic alterations and mouse models | Q34186001 | ||
| Interactions between cancer stem cells and their niche govern metastatic colonization | Q34239769 | ||
| Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. | Q34307548 | ||
| Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma | Q34655394 | ||
| Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme | Q34679133 | ||
| Investigating the link between molecular subtypes of glioblastoma, epithelial-mesenchymal transition, and CD133 cell surface protein. | Q34755413 | ||
| Showering c-MET-dependent cancers with drugs | Q34769397 | ||
| Reciprocal Activation of Transcription Factors Underlies the Dichotomy between Proliferation and Invasion of Glioma Cells | Q34964906 | ||
| Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment | Q35107972 | ||
| STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells | Q35343534 | ||
| Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma | Q35673676 | ||
| Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma | Q35678312 | ||
| Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. | Q36132447 | ||
| Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma | Q36478084 | ||
| Met and hepatocyte growth factor/scatter factor expression in human gliomas | Q36894692 | ||
| A highly invasive human glioblastoma pre-clinical model for testing therapeutics | Q37103825 | ||
| Chondroitin sulfate proteoglycans potently inhibit invasion and serve as a central organizer of the brain tumor microenvironment. | Q37196329 | ||
| Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells | Q37221453 | ||
| Epidermal growth factor (EGF)-enhanced vascular cell adhesion molecule-1 (VCAM-1) expression promotes macrophage and glioblastoma cell interaction and tumor cell invasion | Q37272073 | ||
| Novel therapeutic inhibitors of the c-Met signaling pathway in cancer | Q37422804 | ||
| Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy. | Q37578166 | ||
| The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance | Q37621027 | ||
| Targeting Metabolic Remodeling in Glioblastoma Multiforme | Q37840941 | ||
| Targeting MET in cancer: rationale and progress | Q37978193 | ||
| Glioblastoma and other malignant gliomas: a clinical review. | Q38160159 | ||
| Update on anti-angiogenic treatment for malignant gliomas | Q38186658 | ||
| Extracranial glioblastoma in transplant recipients. | Q38193348 | ||
| The emerging role of MMP14 in brain tumorigenesis and future therapeutics. | Q38198450 | ||
| Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing an invasive and proliferative phenotype | Q38491708 | ||
| Bex2 controls proliferation of human glioblastoma cells through NF-κB signaling pathway | Q39037261 | ||
| RTK Inhibition: Looking for the Right Pathways Toward a Miracle | Q39520882 | ||
| Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype | Q40137229 | ||
| Acid-mediated tumor invasion: a multidisciplinary study | Q40278705 | ||
| Transplanted glioma cells migrate and proliferate on host brain vasculature: a dynamic analysis | Q40303940 | ||
| Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population | Q40590816 | ||
| Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia | Q40835443 | ||
| Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice | Q42041511 | ||
| American Society of Clinical Oncology 2010: report of selected studies from the CNS tumors section | Q42909159 | ||
| Angiogenesis inhibition for glioblastoma at the edge: beyond AVAGlio and RTOG 0825. | Q43088004 | ||
| Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors | Q43244943 | ||
| AACR Special Conference on Epithelial-Mesenchymal Transition and Cancer Progression and Treatment | Q45978304 | ||
| High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene | Q48276455 | ||
| Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens | Q48559424 | ||
| P433 | issue | 12 | |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 1575-1584 | |
| P577 | publication date | 2014-07-30 | |
| P1433 | published in | Neuro-Oncology | Q15724471 |
| P1476 | title | Targeting adaptive glioblastoma: an overview of proliferation and invasion | |
| P478 | volume | 16 |
| Q88945550 | A 3D topographical model of parenchymal infiltration and perivascular invasion in glioblastoma |
| Q100316359 | A microfluidic cell-migration assay for the prediction of progression-free survival and recurrence time of patients with glioblastoma |
| Q37636732 | A role for activated Cdc42 in glioblastoma multiforme invasion. |
| Q48901893 | Added value of amide proton transfer imaging to conventional and perfusion MR imaging for evaluating the treatment response of newly diagnosed glioblastoma |
| Q41103172 | Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers |
| Q37701123 | Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro |
| Q38905432 | Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. |
| Q47834010 | An advanced glioma cell invasion assay based on organotypic brain slice cultures. |
| Q57059935 | Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma |
| Q64244828 | Anti-Invasion and Antiangiogenic Effects of Stellettin B through Inhibition of the Akt/Girdin Signaling Pathway and VEGF in Glioblastoma Cells |
| Q33618479 | Biological basis and clinical study of glycogen synthase kinase- 3β-targeted therapy by drug repositioning for glioblastoma |
| Q64264494 | Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial |
| Q36157355 | Celastrus orbiculatus extract inhibits the migration and invasion of human glioblastoma cells in vitro |
| Q92894347 | Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping |
| Q92833185 | Decreased FBP1 expression rewires metabolic processes affecting aggressiveness of glioblastoma |
| Q57283070 | Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis |
| Q46586294 | Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma |
| Q42328087 | Density-Dependent Regulation of Glioma Cell Proliferation and Invasion Mediated by miR-9. |
| Q48148598 | Developmentally regulated signaling pathways in glioma invasion. |
| Q47099558 | Differential gene expression analysis in glioblastoma cells and normal human brain cells based on GEO database |
| Q98159005 | Dihydropyrimidinase-related protein 5 controls glioblastoma stem cell characteristics as a biomarker of proneural-subtype glioblastoma stem cells |
| Q48164697 | Dissecting Glioma Invasiveness in a 3D-Organotypic Model |
| Q59792916 | Dynamic contrast-enhanced magnetic resonance imaging may act as a biomarker for vascular damage in normal appearing brain tissue after radiotherapy in patients with glioblastoma |
| Q55457200 | EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival. |
| Q55080493 | ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in glioblastoma and participate in PDGFR inhibitor resistance of glioblastoma cells. |
| Q42155868 | Effects of CCN1 and Macrophage Content on Glioma Virotherapy: A Mathematical Model |
| Q36502009 | Emerging targets for glioblastoma stem cell therapy |
| Q64230366 | Ex vivo Dynamics of Human Glioblastoma Cells in a Microvasculature-on-a-Chip System Correlates with Tumor Heterogeneity and Subtypes |
| Q90657489 | Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications |
| Q91760549 | Gene Silencing of TGFβRII Can Inhibit Glioblastoma Cell Growth |
| Q36072027 | Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma |
| Q37585900 | Glioblastoma Induces Vascular Dysregulation in Nonenhancing Peritumoral Regions in Humans |
| Q89605828 | Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance in mice |
| Q89908242 | Heat Shock Cognate Protein 70 Enhanced Integrin β1 Mediated Invasion in Cancer Cells |
| Q36893228 | Homeobox C9 suppresses Beclin1-mediated autophagy in glioblastoma by directly inhibiting the transcription of death-associated protein kinase 1. |
| Q37641789 | Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14. |
| Q93087616 | Human organotypic brain slice culture: a novel framework for environmental research in neuro-oncology |
| Q52724803 | Human tripartite motif protein 52 is required for cell context-dependent proliferation. |
| Q89900060 | Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells |
| Q52721960 | Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells. |
| Q64913905 | Influence of Hyaluronic Acid Transitions in Tumor Microenvironment on Glioblastoma Malignancy and Invasive Behavior. |
| Q36231984 | Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition |
| Q38747813 | Intercellular conduits in tumours: the new social network |
| Q52581527 | Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors |
| Q39268920 | Key rates for the grades and transformation ability of glioma: model simulations and clinical cases |
| Q58747071 | LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients |
| Q38904125 | Let-7f Inhibits Glioma Cell Proliferation, Migration, and Invasion by Targeting Periostin |
| Q36705891 | Loss of endothelial programmed cell death 10 activates glioblastoma cells and promotes tumor growth |
| Q48682137 | MINA controls proliferation and tumorigenesis of glioblastoma by epigenetically regulating cyclins and CDKs via H3K9me3 demethylation. |
| Q47569610 | Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients |
| Q27305151 | Mechanical confinement triggers glioma linear migration dependent on formin FHOD3. |
| Q38386429 | Mechanisms regulating glioma invasion |
| Q47164243 | Melatonin attenuates hypoxia-induced epithelial-mesenchymal transition and cell aggressive via Smad7/ CCL20 in glioma |
| Q41138932 | MiR-301a is activated by the Wnt/β-catenin pathway and promotes glioma cell invasion by suppressing SEPT7. |
| Q46190130 | MicroRNA-target cross-talks: Key players in glioblastoma multiforme |
| Q48159135 | Modeling phenotypes of malignant gliomas |
| Q47183915 | Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles |
| Q92996626 | Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells |
| Q38697415 | Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion |
| Q35923158 | Multi-modal imaging of tumor cellularity and Tryptophan metabolism in human Gliomas |
| Q57804906 | Multimodal Imaging-defined Subregions in Newly-diagnosed Glioblastoma: Impact on Overall Survival |
| Q64971917 | Myosin IIA suppresses glioblastoma development in a mechanically sensitive manner. |
| Q40361388 | Near infrared fluorescent imaging of brain tumor with IR780 dye incorporated phospholipid nanoparticles |
| Q64910172 | On the Impact of Chemo-Mechanically Induced Phenotypic Transitions in Gliomas. |
| Q64238329 | Oncogenic MSH6-CXCR4-TGFB1 Feedback Loop: A Novel Therapeutic Target of Photothermal Therapy in Glioblastoma Multiforme |
| Q43709913 | Organotypic brain explant culture as a drug evaluation system for malignant brain tumors. |
| Q97543483 | Overexpression of HGF/MET axis along with p53 inhibition induces de novo glioma formation in mice |
| Q90419003 | Patient-Derived Glioma Models: From Patients to Dish to Animals |
| Q55456996 | Patterns of Invasive Growth in Malignant Gliomas-The Hippocampus Emerges as an Invasion-Spared Brain Region. |
| Q37520563 | Preclinical effects of CRLX101, an investigational camptothecin-containing nanoparticle drug conjugate, on treating glioblastoma multiforme via apoptosis and antiangiogenesis |
| Q36905859 | Preferential expression of functional IL-17R in glioma stem cells: potential role in self-renewal |
| Q51138357 | Prognostic Molecular and Imaging Biomarkers in Primary Glioblastoma |
| Q39368650 | RNA processing as an alternative route to attack glioblastoma. |
| Q35764111 | Radioiodinated PARP1 tracers for glioblastoma imaging |
| Q28551757 | Serum-Induced Differentiation of Glioblastoma Neurospheres Leads to Enhanced Migration/Invasion Capacity That Is Associated with Increased MMP9 |
| Q89975399 | Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening |
| Q64099481 | Strategies in regulating glioblastoma signaling pathways and anti-invasion therapy |
| Q92557155 | TIGAR promotes growth, survival and metastasis through oxidation resistance and AKT activation in glioblastoma |
| Q90396131 | The Bradykinin-BDKRB1 Axis Regulates Aquaporin 4 Gene Expression and Consequential Migration and Invasion of Malignant Glioblastoma Cells via a Ca2+-MEK1-ERK1/2-NF-κB Mechanism |
| Q90363306 | The Roles of miRNA in Glioblastoma Tumor Cell Communication: Diplomatic and Aggressive Negotiations |
| Q89088558 | The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance |
| Q26795601 | The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics |
| Q51205890 | The role of DNA methylation in ST6Gal1 expression in gliomas |
| Q36271552 | The role of myosin II in glioma invasion: A mathematical model |
| Q92004811 | Treatment Strategies Based on Histological Targets against Invasive and Resistant Glioblastoma |
| Q36952693 | Tryptophan PET Imaging of the Kynurenine Pathway in Patient-Derived Xenograft Models of Glioblastoma |
| Q37432387 | Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI. |
| Q57040103 | Zeb1 potentiates genome-wide gene transcription with Lef1 to promote glioblastoma cell invasion |
Search more.